Abstract
study in two stages. First, we attempted to verify the reliability of using the history, the clinical examination, and the skin-prick allergen test as a definitive method of diagnosing allergic rhinitis; two groups of subjects were recruited for this purpose (the positive control group and the negative control group) . Once we validated the reliability of this method, we used these diagnostic criteria to determine the prevalence of allergic rhinitis in patients with newly diagnosed butnot-yet-treated nasopharyngeal carcinoma (the carcinoma group) .
Positive control group. The positive control group was made up of22 subjects-I 7 men and five women, aged 25 to 68 years (mean: 45.0)-who were known to have nasal allergy . They had been selected from the case load at our otolaryngology outpatient clinic. These subjects all had the typical history and clinical findings associated with allergic rhinitis, especially during exposure to dust. At the time of their skin -prick test, no patient had taken an antihistamine during the previous 7 days.
Negative control group. The negative control group was made up of 22 healthy subjects-I7 men and five women, aged 24 to 65 year s (mean: 43.0)-who did not have any nasal alle rgy. This group was assembled from patients and hospital staff members in an effort to create a group that resembled a normal population. The members of both control groups were carefully selected to ensure that they were age-and sex-matched with the patients in the carcinoma group .
Carcinoma group . The carcinoma group was made up of 22 patients-17 men and five women, aged 25 to 67 years (mean: 43 .5)-who had been newly diagnosed with nasopharyngeal carcinoma.The carcinoma group included 19 Chinese (15 men and four women) and three Malays (two men and one woman).
The patients in the carcinoma group had had their diagnosis confirmed by histology, but they had not yet undergone any treatment for their carcinoma. For this study, they were interviewed by que stionnaire, and they were asked about any personal history or symptoms of food or environmental allergy and any family history of allergy . They also underwent a clinical examination to identify any evidence of allergy , with special emphasis on the nasal examination.
Skin-prick testing ofthe two control groups was carried out in the otolaryngology outpatient clinic or in the otolaryngology ward of the hospital, where resuscitation equipment was available. Patients in the carcinoma group underwent skin-prick testing at our center's Department of Immunology.
During all skin-prick tests, 15 allergens and three control solutions were used (table) . The allergens included foodstuffs, aeroallergens, and animal and insect components that commonly provoke allergic reactions in Malaysia. Two concentrations of histamine (1 mg/ml and 10 mg/ ml) were used as positive controls, and phosphate-buffered saline (PBS), the carrier substance in diluting the allergens, was used as the negative control. The PBS was prepared so that it resembled the concentration and pH level of serum in the body. In order to avoid any investigator error, a single researcher (N.P.) conducted all skinprick tests.
Skin-prick tests were conducted by making 18 pricks on the forearm; each site was numbered to correspond to a particular antigen or control. A 6-fJldrop of each antigen solution was applied to the forearm with a pipette. A sterile lancet or 25-gauge needle was used to puncture the skin through the solution. Lancets and needles were cleaned with PBS solution after each prick. Excess allergen was removed from the skin with an absorbent paper tissue. Reactions were evaluated after 15 minutes.
The results of the skin-prick tests were interpreted in conjunction with each patient's history and clinical findings. When the history and the skin test were positive, a diagnosis of allergy was confirmed. When they were negative, allergy was excluded. A skin test was considered to be positive if the allergen produced an induration either larger than 3 mm or larger than the reaction produced by the positive control. If the negative control caused a reaction, the results of that particular test were considered to be unreliable.
Results
Inthe positive control group, all 22 patients had a positive skin test (figure). In the negative control group, positive skin-prick tests were seen in three of the 22 patients (13.6%) (figure) . Upon further questioning, one of these patients admitted to having experienced occasional rhinitis and sneezing during spring cleaning, but these symptoms had not caused him any inconvenience and he had not considered them bothersome enough to report. Another negative control who tested positive on skin-prick 
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Oyster Soybean Shrimp testing said that he had experienced allergic manifestations (e.g., sneezing) during childhood, but he had been symptom-free ever since. In all, we considered our findings conclusive enough to validate our diagnostic criteria .
In the carcinoma group, only one of the 22 patients (4.5%), a Malay man, had a positive skin test (figure). Although the results of his clinical examination were normal, he did provide a typical history of vasomotor rhinitis-that is, nasal congestion during exposure to cold air. No other patient in the carcinoma group had a personal or family history of nasal symptoms or allergy.
Discussion
The diagnosis of nasal allergy based only on the history and clinical findings can be difficult. The addition of skinprick testing, however, has helped make the diagnosis more reliable. ' Our first goal was to test this reliability by using the two control groups, and we succeeded. All 22 patients who had a history and clinical evidence of allergic rhinitis had a positive skin-prick test. Conversely, 19 of the 22 patients in our negative control group (86.4 %) had a negative skin-prick test, and two of the three whose Our findi ngs lead us to ask several ques tions:
• Could there be a corre lation between T-cell production in allergy and the low incidence of allergy in nasoph aryngeal carci noma ? The possibility that the number of cytotox ic T cells and other T-cell subunits increases in patients with allergy warra nts further study . Documentation has already been established that cellmediated immun ity is depressed in patients with nasopharyngeal carcinoma." • Is it possi ble that patients with allergy experience cross-reac tivity and an increase in cytotoxic T cell s dur ing the activation of T lymphocytes that leads to an increase in cell-mediated immunity? • Is it possibl e that the hum oral immunity involved in allergy affects the cell-me diated immunity that regulates neoplastic proliferations (e.g ., natural killer cells or cytotox ic cells)? • Or is it possible that an increase in nasal discharge and rhinitis results in less co ntact between carcinoge ns and RosenmUller ' s fossa in patient s with allergic rhinitis?
The answers to these questions lie beyond the scope of our study and need to be addresse d in further resea rch. tests were positive actually had experienced some degree of allerg ic symptoms in the past. Therefore, we concluded that the com bination of the history, clinica l examination, and a skin-pric k test is a reliable indica tor of the presence or absence of nasal allergy .
Having estab lished the validity of our diagnostic criteria, we set about to co nfirm or rule out the presence of allergic rhinitis in the 22 patient s who had been newly diagnosed with nasopharyngeal carci noma. Using these criteria, we found that only one of these patients (4.5%) had allergic rhinitis. Although his clinical finding s did not correspond to his history and skin test results, we concluded that the latter two criteria represented a positive result. It is possible that this patient had intr insic rhinitis and that his allergy was not associated with his nasal symptoms. Therefo re, we conclu de that there appears to be an inverse relationship between nasoph aryngeal carcinoma and nasal allerg y.
The role of immunology in onco logy research is well known. Cytot oxic T cells and natur al killer T cells for m part of the highly efficient defense mechanism that keeps the occasional ectopic malignant cell in check .T-lymphocyte dysregul ation has been found to play a majo r role in airway allergy .' Recent evidence sugges ts that T-lymph ocyte activation, the recruitment of TH2 cells, and the generation of TH2 cytokines (particularly interleukins 4 and 5) lead to loca l tiss ue eosinophilia and IgE mast-cell activation." Thi s allergen-induced T-cell activa tion is more marked in the nose than in other parts of the airway ." It has been established that T cells, their subsets (particularly TH2), and their cytokines play a major role in allergy.>"
